KarmelSonix technology offers immense advantages with respect to the capture, storage and analysis of respiratory sounds objectively and without relying on patient cooperation.

KarmelSonix is dedicated to providing a full range of products, all based on its core technology, but implemented in the configuration that is most appropriate for its use – from a patient’s home to the Intensive Care Unit.

KarmelSonix Ltd is a joining of two sector leaders, each with a unique proprietary respiratory acoustic technology:

• KarmelSonix (Israel): Passive technology; an ingenious technique to listen and analyze the lung acoustics generated during the respiratory cycle.
• Pulmosonix (Australia): Active technology that focuses on injecting sounds into the thorax and picking the changed signal at various locations, reaching diagnostic conclusions from the sound propagation data.

The synergy between the technologies and the ability to combine the two approaches, allows Karmelsonix to offer solutions no other market player can tackle. It resolves clinical challenges previously deemed impossible.

KarmelSonix is proud to present its latest products and services:

	PulmoTrack® An excellent choice for asthma monitoring and for patients who cannot perform spirometry; such as small children, elderly and acute asthmatics.
	Wholter™ A 24-hours wheezing and cough recorder in the patient’s own allergen environment and for evaluation of Nocturnal Asthma.
	Personal Wheezometer™ A home use personal novel device provides the patient with real online information as to his Wheeze rate situation.
ASAM, Acoustic Severe Asthma Monitor Technology aimed at the emergency medicine and intensive care units, focusing on injecting sounds into the thorax and picking up the changed signal at various locations, reaching diagnostic conclusions from the sound propagation data.

The KarmelSonix technology offers immense advantages with respect to the capture, storage and analysis of respiratory sounds objectively and without relying on patient cooperation.

KarmelSonix is dedicated to providing a full range of products, all based on its core technology but implemented in the configuration that is most appropriate for its use – from the patient’s home to the Intensive Care Unit.

Mr. Ross Haghighat - Interim Chairman of the Board

Mr. Ross Haghighat is a serial entrepreneur with nearly 25 years of experience in founding and transforming companies in the high tech fields of telecommunications, sensors and diagnostics, biotechnology, and specialty materials. He is the founding CEO of Triton Systems, Inc., a leading product venturing company headquartered in Chelmsford Massachusetts, a suburb of Boston and with offices in Boston, Washington DC, and Fargo, North Dakota. Mr. Haghighat serves on the Board of a number of for profit firms: Triton Systems, Aduro BioTech,
SI2 Technologies, FRX Polymers Sensera.

Mr. Paul Hopper - Director

Paul Hopper has over 20 years international experience in the management and funding of life science and healthcare companies, and has served on the Boards of more than a dozen public companies in the US, Asia and Australia. Mr. Hopper is a Director of pSivida Corp, a Director of Fibrocell Science Inc, the Chairman of Viralytics Limited, and a Director of Somnomed Ltd. Mr. Hopper is Managing Director at the Los Angeles based Investment Bank, Cappello Group where he heads the Australia Desk and the Life Sciences practice.

Mr. Jerry Korten - Director

Jerry Korten was CEO of Versamed, Inc. an Israeli startup he helped establish as a US company that was sold to GE Healthcare. Currently Jerry, as General Manager of Strategic Markets, is working with GE Healthcare to identify new opportunities to advance technology in the field of cardiopulmonary therapy, monitoring and diagnosis. Jerry also serves as a mentor to the New York City Investment Fund's BioAccelerate Program to catalyze the creation of a life sciences industry sector in the city by increasing the number of commercial spin-offs from New York’s universities and research institutions. Jerry has served on the boards of diagnostic and therapeutic device companies including Versamed, Inc., Bunnel Inc. and Vitaltrends Technology, Inc. and brings operational expertise in running medical device companies including engineering management as well as management experience in sales and marketing.

Mr. Fabio Pannuti - Director

Fabio Pannuti has served on the board of several public companies listed in Australia, the United Kingdom and North America over the last 20 years and also a number of private investment vehicles. These companies have had significant and successful involvement in diverse areas including agriculture, property development, mining/oil and gas, telecommunications, wholesale debt purchase and biotech. These have included The Van Diemen's Land Company, to recently being Chairman of Mobi Ltd, a small diverse telco.

Fabio is currently Chairman of Cairngorm Leisure, a company involved in the development of a snow dome, hotel and leisure complex in Australia and also serves on the board of Leading Edge Instruments Ltd, a company that develops medical devices.

Mr. Paul Eisen - Executive Director, Sales & Marketing for Europe, Asia Pacific & Australia - Australia

Paul Eisen has operated as a senior executive in the Medical device and Healthcare industry across Australia and Asia Pacific for the last 20 years.

Paul holds a degree in Diagnostic Radiography from Sydney Technical Institute and a Graduate Diploma in Marketing from the University of Technology, Sydney ( UTS ).

No info available.